ANDA 70259, held by Natco. Tolazamide.
As of Nov 21, 2026, ANDA 70259 (Tolazamide), held by Natco, was first approved by FDA on Nov 7, 1986, with 13 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 7, 1986 | Original application | Approved | None posted |
| Tolazamide250MG · tablet;oral | Tolazamide | Discontinued |
| Tolazamide500MG · tablet;oral | Tolazamide | Discontinued |
| Mar 10, 2010 | Supplement 23Labeling | Approved | None posted |
| Nov 20, 2009 | Supplement 22Labeling | Approved | None posted |
| Jan 10, 2002 | Supplement 16Labeling | Approved | None posted |
| Mar 10, 2000 | Supplement 15Labeling | Approved | None posted |
| Sep 20, 1999 | Supplement 14Manufacturing | Approved | None posted |
| Feb 25, 1998 | Supplement 12Manufacturing | Approved | None posted |
| Feb 5, 1998 | Supplement 13Manufacturing | Approved | None posted |
| Nov 15, 1993 | Supplement 10Manufacturing | Approved | None posted |
| Mar 26, 1991 | Supplement 8Labeling | Approved | None posted |
| Feb 5, 1991 | Supplement 7Labeling | Approved | None posted |
| Jan 31, 1990 | Supplement 6Manufacturing | Approved | None posted |
| Jul 27, 1989 | Supplement 5Labeling | Approved | None posted |
| Nov 7, 1986 | Original application | Approved | None posted |
| Mar 21, 1986 | Supplement 1Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters